Skip to main content

Calibre Scientific Acquires BrightBox Quantitation, A US Reagent Manufacturer Specializing in NGS Library Quantitation

Written by Customer Service on . Posted in Mergers And Acquisitions.

LOS ANGELES, Jan. 12, 2022 (GLOBE NEWSWIRE) — Calibre Scientific is pleased to announce the acquisition of BrightBox Quantitation, a highly specialized reagent manufacturer headquartered in San Mateo, California. BrightBox Quantitation produces and distributes a proprietary assay kit for rapid quantification of DNA or RNA NGS library molecules. BrightBox Quantitation joins EdgeBio, a division of Calibre Scientific, further enhancing Calibre Scientific’s presence in the DNA sequencing sector.

“A market leader in DNA sequencing for decades, EdgeBio has built a reputation for high-quality consumables that help its customers save time and money across the sequencing workflow,” said Avesta Ebrahimi, General Manager of EdgeBio. “We’re excited to add BrightBox Quantitation kits to our portfolio: they will make NGS workflows faster, easier, and more cost-effective for our customers, allowing them to increase throughput capacity and deliver consistent, high-quality results.”

“We are really excited to partner with Calibre Scientific, a company that supplies exceptional lab consumables to scientists worldwide,” said Dr. Richard Fekete, CEO and Founder of BrightBox Quantitation. “The simplified workflow of the BrightBox Assay for NGS library quantitation fits in perfectly with Calibre Scientific’s customer-focused product portfolio. With Calibre Scientific’s world-class manufacturing and sales capabilities, we will now be able to bring these assays to a much broader set of customers.”

About Calibre Scientific

Calibre Scientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics, industrial, and biopharmaceutical communities. Calibre Scientific owns a portfolio of life science and diagnostic companies that have an unrivaled ability to address the unique challenges of their respective markets. Our global reach extends to over 100 countries, empowering customers all over the world. Headquartered in Los Angeles, California, Calibre Scientific continues to expand its product offering and global footprint to laboratories across a wide array of verticals and geographies. 

For more information, visit www.calibrescientific.com, or contact Brice Geoffrion, Director of Business Development, at bgeoffrion@calibrescientific.com, or +1 (310) 651-8285.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.